Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Ethylenediamine | HCID 3301 | — |
| Reactant | Ethyl Acetate | HCID 8857 | — |
| Reactant | Tetrabutylammonium Fluoride | HCID 2724141 | — |
| Reactant | HCID 86762630 | HCID 86762630 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 78132840 | HCID 78132840 | 64.7% |
Reaction Steps
To a stirred solution of N4-(5-cyclopropyl-1H-pyrazol-3-yl)-N2-ethyl-N2-(1-(5-((2-(trimethylsilyl)ethoxy)methyl)-5H-pyrrolo[3,2-d]pyrimidin-2-yl)ethyl)pyrimidine-2,4-diamine (103.9 mg, 0.20 mmol) in anhydrous DMF (4.7 mL) was added ethylenediamine (0.10 mL, 1.60 mmol) followed by tetrabutylammonium fluoride (1M in THF, 0.60 mL, 0.60 mmol), and the reaction mixture was stirred at 80° C. under N2 for 20 h. The reaction mixture was poured into EtOAc, and the organic layer was washed with 10% aq. NaOH solution, water and brine, dried (Na2SO4), filtered, and concentrated under reduced pressure. The crude product was purified by SiO2 chromatography to afford 50.4 mg (64.7%) of racemic N2-(1-(5H-pyrrolo[3,2-d]pyrimidin-2-yl)ethyl)-N4-(5-cyclopropyl-1H-pyrazol-3-yl)-N2-ethylpyrimidine-2,4-diamine. Chiral SFC chromatography of racemic N2-(1-(5H-pyrrolo[3,2-d]pyrimidin-2-yl)ethyl)-N4-(5-cyclopropyl-1H-pyrazol-3-yl)-N2-ethylpyrimidine-2,4-diamine (50.4 mg, 0.13 mmol) afforded the corresponding two enantiomers:
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08815877B2 |
|---|
| Source dataset | uspto-grants-2014_08 |
|---|
| ORD ID | ord-c58693a858e340a18cdee2b65261a369 |
|---|
| Source note | uspto-grants-2014_08 |
|---|